Cargando…
Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis
BACKGROUND: The aim of this exploratory study is to gain for the first time a more comprehensive picture of the impact of changes of quinolinic acid concentrations on depressive symptomatology during and after IFN-α therapy. METHODS: The quinolinic acid concentrations of 35 HCV patients are examined...
Autores principales: | Baranyi, Andreas, Meinitzer, Andreas, Breitenecker, Robert J., Amouzadeh-Ghadikolai, Omid, Stauber, Rudolf, Rothenhäusler, Hans-Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569409/ https://www.ncbi.nlm.nih.gov/pubmed/26368809 http://dx.doi.org/10.1371/journal.pone.0137022 |
Ejemplares similares
-
Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression
por: Baranyi, Andreas, et al.
Publicado: (2018) -
Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach
por: Baranyi, Andreas, et al.
Publicado: (2017) -
Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity
por: Baranyi, Andreas, et al.
Publicado: (2017) -
Nitric Oxide-Related Biological Pathways in Patients with Major Depression
por: Baranyi, Andreas, et al.
Publicado: (2015) -
Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder
por: Baranyi, Andreas, et al.
Publicado: (2016)